Parkinson’s Disease Treated By Therapeutic Cloning In Mouse Model

Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice. The study’s results are published in the March 23 online edition of the journal Nature Medicine.

More: continued here

Filed under: Parkinson's Disease on April 2nd, 2008